On March 31, Jiang Yuyang, Deputy Director of the Standing Committee of Shenzhen Municipal People’s Congress and Chairman of Shenzhen Association for Science and Technology, and other delegation members visited China Medical System (“CMS” or the “Group”) to gain an in-depth understanding of the resumption of work and production and the business development of the company. Mr. Lam Kong, Chairman and Chief Executive of CMS, Ms. Chen Yanling, Executive Director and Vice President of CMS, and others received the visiting group.
Deputy Director Jiang Yuyang and his entourage listened carefully to the reports on the Group’s achievements made in the past three decades, its path of innovative research and development and the progress of innovative products in China. Leveraging the open innovative medicine platform connecting global innovation and commercialization, CMS has actively promoted the transformation and launching of overseas and domestic innovative technologies in Shenzhen, contributing to the development of innovative pharmaceutical technologies in Shenzhen.
Deputy Director Jiang Yuyang affirmed the achievements made by CMS in innovative medicine development in recent years, and praised its innovative research and transformation model. He commented that CMS’ new models of developing innovative products from the perspective of internationalization and commercialization is suitable for Shenzhen and will bring a new insight into the development of Shenzhen’s biopharmaceutical industry. Deputy Director Jiang Yuyang also made a profound discussion on innovative technology development, innovative research centers and other topics of Shenzhen government.
At the meeting, Deputy Director Jiang Yuyang asked about the resumption of work and production of the Group and the related difficulties, and affirmed the Group’s positive acts in pandemic prevention and control. Since the outbreak of the pandemic, CMS has quickly responded to the decisions of Shenzhen government, strictly protected its employees from being infected, donated funds for particular agricultural materials to support the frontline anti-pandemic personnel in Nanshan District, well-organized the resumption of work and production, stabilized the employment and guaranteed the supply of medicines. CMS has fulfilled its responsibility as a pharmaceutical enterprise with all these concrete actions.
Huang Man’e (Deputy Secretary of the Standing Committee of Shenzhen Municipal People’s Congress), Sun Fujin, (Director of the Education, Science, Culture and Public Health Committee), Xiong Qiubing (Director of the Office of the Education, Science, Culture and Public Health Committee), Guo Junshan (Deputy Director of the Office of the Education, Science, Culture and Public Health Committee), Wen Zhihong (Liaison), Sun Nan (Party Member of Shenzhen Association for Science and Technology), Li Song (Director of the Communication Center of Science and Technology) also participated in this visit.